Thai Ministry ignores cancer drug patents
Patient Safety Monitor: Global Edition, March 18, 2008
In an effort to increase public health efforts, Thailand's new health minister has urged the nation's government to ignore patents on several cancer drugs, frustrating efforts of big pharmaceutical companies, reports The Wall Street Journal.
The ministry spokesperson said the decision was made in an effort to lower costs of medicines for Thai residents, according to the Journal.
To read more, click here.
Comments
0 comments on “Thai Ministry ignores cancer drug patents ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q&A: Coding for dry skin due to cold weather
- Q/A: Volume requirement for reporting hydration services
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Privacy, security concerns high in HIEs
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- HIPAA Q&A: TPO disclosures to a business associate
- Are your workforce members texting PHI?
- Q&A: Coding for dry skin due to cold weather
- Hospitalist-surgeon comanagement has no effect on outcomes
- Don't let these sentinel events trigger falsely
- Correctly bill ancillary bedside procedures in addition to the room rate
- Searched
